What are the generic versions of obeticholic acid? Quality and selection reference
Obeticholic acid is an innovative drug used to treat liver diseases such as primary biliary cholangitis (PBC). Although it has been recognized in the international market, as of now, obeticholic acid has not been officially approved for marketing in my country, so domestic patients need to purchase it through overseas channels. Due to the high prices of imported drugs, generic drugs have become the focus of patients' attention.
At present, in addition to original drugs, there are also a variety of generic versions on the foreign market, especially in large countries such as India that produce generic drugs. These generic drugs are provided to patients at lower prices. For example, the price of a generic obeticholic acid drug produced by Mylan Pharmaceuticals in India is less than 1,000 yuan, which is many times lower than the price of the original drug. This price advantage greatly reduces patients' financial burden and improves drug accessibility.
Regarding the quality of generic drugs, generic drugs in countries such as India usually need to undergo strict process verification and quality control to ensure that the active ingredients are basically the same as the original drugs and have good bioequivalence. Although the clinical data of generic drugs is not as rich as that of original drugs, in most cases, generic drugs produced in compliance with regulations can meet clinical needs in terms of efficacy and safety. Patients should pay attention to the production qualifications and source channels of drugs when choosing, and avoid using uncertified informal products.
In summary, the generic version of obeticholic acid provides domestic patients with an affordable treatment option. With the continuous improvement of generic drug technology and the improvement of the regulatory system, in the future such drugs are expected to better meet the needs of patients while ensuring quality, and promote the promotion and popularization of this drug in the country.
Reference materials:https://www.drugs.com
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)